Evidence map›Paper›PMID 31327566›Full record

SynthesisLancet (London, England)2019

The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1·1 million adults.

Pascal Geldsetzer, Jennifer Manne-Goehler, Maja-Emilia Marcus, Cara Ebert, Zhaxybay Zhumadilov, Chea S Wesseh, Lindiwe Tsabedze, Adil Supiyev, Lela Sturua, Silver K Bahendeka and 33 more

2 registry-linked trialsOpen access · greenAbstract readMeta-Analysis
PubMed Publisher
In one paragraph

Synthesis in Lancet (London, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 380 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
380citing papers in PubMed, 6 pooled it
80.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04505150 naunknown statusnot on this mapstarted 2020, after this paper: background citation

Lowering Blood Pressure by Changing Lifestyle Through a Motivational Education Program: a Cluster RCT Study Protocol

TypeinterventionalSponsorOrganisation for Rural Community Development, BangladeshRan2020 to 2022Enrolled300ConditionsHigh Blood PressureArmsLifestyle changes, e.g., take part in regular exercise, quitting smoking, and reduce salt consumption
NCT06258473 phase1recruitingnot on this mapstarted 2024, after this paper: background citation

Addressing Gaps in the Hypertension and Diabetes Care Continuum in Rural Bangladesh Through mHealth and Decentralized Primary Care: The Dinajpur Study

TypeinterventionalSponsorBRAC UniversityRan2024 to 2026Enrolled6,750ConditionsHypertension, DiabetesArmsMulticomponent decentralized care, mHealth
3 · Its place in the literature

Who cites it

380 citing papers in PubMed, 6 syntheses or guidelines pooled it, 846 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Systematic Review Article: New Drug Strategies for Treating Resistant Hypertension-the Importance of a Mechanistic, Personalized Approach.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2024
    Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Article

320 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

43 authors at 20 institutions in 25 countries.

Pascal GeldsetzerDepartment of Global Health and Population, Harvard T H Chan School of Public Health, Boston, MA, USA.
Jennifer Manne-GoehlerDepartment of Global Health and Population, Harvard T H Chan School of Public Health, Boston, MA, USA; Division of Infectious Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Maja-Emilia MarcusDepartment of Economics and Centre for Modern Indian Studies, University of Göttingen, Göttingen, Germany.
Cara EbertDepartment of Economics and Centre for Modern Indian Studies, University of Göttingen, Göttingen, Germany; RWI-Leibniz Institute for Economic Research, Berlin, Germany.
Zhaxybay ZhumadilovNational Laboratory Astana, University Medical Center, Nazarbayev University, Astana, Kazakhstan.
Chea S WessehMinistry of Health, Monrovia, Liberia.
Lindiwe TsabedzeMinistry of Health, Mbabane, eSwatini.
Adil SupiyevLaboratory of Epidemiology and Public Health, Center for Life Sciences, Nazarbayev University, Astana, Kazakhstan.
Lela SturuaNon-Communicable Diseases Department, National Center for Disease Control and Public Health, Tbilisi, Georgia.
Silver K BahendekaSt Francis Hospital Nsambya, Kampala, Uganda.
Abla M SibaiEpidemiology and Population Health Department, Faculty of Health Sciences, American University of Beirut, Beirut, Lebanon.
Sarah Quesnel-CrooksNon-Communicable Diseases, Caribbean Public Health Agency, Port of Spain, Trinidad and Tobago.
Bolormaa NorovNational Center for Public Health, Ulaanbaatar, Mongolia.
Kibachio J MwangiDivision of Non-Communicable Diseases, Ministry of Health, Nairobi, Kenya; The Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Omar MwalimMinistry of Health, Zanzibar City, Tanzania.
Roy Wong-McClureOffice of Epidemiology and Surveillance, Costa Rican Social Security Fund, San José, Costa Rica.
Mary T MayigeNational Institute for Medical Research, Dar es Salaam, Tanzania.
Joao S MartinsFaculty of Medicine and Health Sciences, National University of East Timor, Dili, Timor-Leste.
Nuno LunetDepartment of Public and Forensic Health Sciences and Medical Education, Faculty of Medicine, University of Porto, Porto, Portugal.
Demetre LabadariosFaculty of Medicine and Health Sciences, Stellenbosch University, Stellenbosch, South Africa.
Khem B KarkiDepartment of Community Medicine and Public Health, Institute of Medicine, Tribhuvan University, Kathmandu, Nepal.
Gibson B KagarukiNational Institute for Medical Research, Dar es Salaam, Tanzania.
Jutta M A JorgensenD-Tree International, Boston, MA, USA.
Nahla C HwallaFaculty of Agricultural and Food Sciences, American University of Beirut, American University of Beirut, Beirut, Lebanon.
Dismand HouinatoLaboratory of Epidemiology of Chronic and Neurological Diseases, Faculty of Health Sciences, University of Abomey-Calavi, Cotonou, Benin.
Corine HouehanouLaboratory of Epidemiology of Chronic and Neurological Diseases, Faculty of Health Sciences, University of Abomey-Calavi, Cotonou, Benin.
Mohamed MsaidiéMinistry of Health, Solidarity, Social Cohesion and Gender, Government of Comoros, Moroni, Comoros.
David GuwatuddeDepartment of Epidemiology and Biostatistics, School of Public Health, Makerere University, Kampala, Uganda.
Mongal S GurungHealth Research and Epidemiology Unit, Ministry of Health, Thimphu, Bhutan.
Gladwell GathechaDivision of Non-Communicable Diseases, Ministry of Health, Nairobi, Kenya.
Maria DorobantuDepartment of Cardiology, Emergency Hospital of Bucharest, Bucharest, Romania.
Albertino DamascenoDepartment of Public and Forensic Health Sciences and Medical Education, Faculty of Medicine, University of Porto, Porto, Portugal; EPIUnit, Institute of Public Health, University of Porto, Porto, Portugal; Faculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique.
Pascal BovetCenter for Primary Care and Public Health, University of Lausanne, Lausanne, Switzerland; Ministry of Health, Victoria, Seychelles.
Brice W BicabaInstitut Africain de Santé Publique, Ouagadougou, Burkina Faso.
Krishna K AryalDepartment for International Development/Nepal Health Sector Programme 3/Monitoring Evaluation and Operational Research, Abt Associates, Kathmandu, Nepal.
Glennis Andall-BreretonNon-Communicable Diseases, Caribbean Public Health Agency, Port of Spain, Trinidad and Tobago.
Kokou AgoudaviMinistry of Health, Lome, Togo.
Andrew StokesDepartment of Global Health, Boston University School of Public Health, Boston, MA, USA.
Justine I DaviesMRC/Wits Rural Public Health and Health Transitions Research Unit, School of Public Health, University of Witwatersrand, Johannesburg, South Africa; Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
Till BärnighausenDepartment of Global Health and Population, Harvard T H Chan School of Public Health, Boston, MA, USA; Africa Health Research Institute, Somkhele, South Africa; Heidelberg Institute of Global Health, Faculty of Medicine, University of Heidelberg, Heidelberg, Germany. Electronic address: till.baernighausen@uni-heidelberg.de.
Rifat AtunDepartment of Global Health and Population, Harvard T H Chan School of Public Health, Boston, MA, USA; Department of Global Health and Social Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Sebastian VollmerDepartment of Economics and Centre for Modern Indian Studies, University of Göttingen, Göttingen, Germany.
Lindsay M JaacksDepartment of Global Health and Population, Harvard T H Chan School of Public Health, Boston, MA, USA; Public Health Foundation of India, New Delhi, Delhi, India.
University of Göttingen · DEAmerican University of Beirut · LBCaribbean Public Health Agency · TTHarvard Global Health Institute · USHarvard University · USNational Institute for Medical Research · TZNazarbayev University · KZUniversidade do Porto · PTUniversité d'Abomey-Calavi · BJAbt Associates (Nepal) · NPBoston University · USClinical Emergency Hospital Bucharest · ROCosta Rican Department of Social Security · CRD-Tree International · USInstitut de Recherche en Sciences de la Santé · BFMakerere University · UGMinistry of Health · SCMinistry of Health · SZMinistry of Health · KENational Center for Communicable Diseases · MN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEvidence from nationally representative studies in low-income and middle-income countries (LMICs) on where in the hypertension care continuum patients are lost to care is sparse. This information, however, is essential for effective targeting of interventions by health services and monitoring progress in improving hypertension care. We aimed to determine the cascade of hypertension care in 44 LMICs-and its variation between countries and population groups-by dividing the progression in the care process, from need of care to successful treatment, into discrete stages and measuring the losses at each stage.

methodsIn this cross-sectional study, we pooled individual-level population-based data from 44 LMICs. We first searched for nationally representative datasets from the WHO Stepwise Approach to Surveillance (STEPS) from 2005 or later. If a STEPS dataset was not available for a LMIC (or we could not gain access to it), we conducted a systematic search for survey datasets; the inclusion criteria in these searches were that the survey was done in 2005 or later, was nationally representative for at least three 10-year age groups older than 15 years, included measured blood pressure data, and contained data on at least two hypertension care cascade steps. Hypertension was defined as a systolic blood pressure of at least 140 mm Hg, diastolic blood pressure of at least 90 mm Hg, or reported use of medication for hypertension. Among those with hypertension, we calculated the proportion of individuals who had ever had their blood pressure measured; had been diagnosed with hypertension; had been treated for hypertension; and had achieved control of their hypertension. We weighted countries proportionally to their population size when determining this hypertension care cascade at the global and regional level. We disaggregated the hypertension care cascade by age, sex, education, household wealth quintile, body-mass index, smoking status, country, and region. We used linear regression to predict, separately for each cascade step, a country's performance based on gross domestic product (GDP) per capita, allowing us to identify countries whose performance fell outside of the 95% prediction interval.

findingsOur pooled dataset included 1 100 507 participants, of whom 192 441 (17·5%) had hypertension. Among those with hypertension, 73·6% of participants (95% CI 72·9-74·3) had ever had their blood pressure measured, 39·2% of participants (38·2-40·3) had been diagnosed with hypertension, 29·9% of participants (28·6-31·3) received treatment, and 10·3% of participants (9·6-11·0) achieved control of their hypertension. Countries in Latin America and the Caribbean generally achieved the best performance relative to their predicted performance based on GDP per capita, whereas countries in sub-Saharan Africa performed worst. Bangladesh, Brazil, Costa Rica, Ecuador, Kyrgyzstan, and Peru performed significantly better on all care cascade steps than predicted based on GDP per capita. Being a woman, older, more educated, wealthier, and not being a current smoker were all positively associated with attaining each of the four steps of the care cascade.

interpretationOur study provides important evidence for the design and targeting of health policies and service interventions for hypertension in LMICs. We show at what steps and for whom there are gaps in the hypertension care process in each of the 44 countries in our study. We also identified countries in each world region that perform better than expected from their economic development, which can direct policy makers to important policy lessons. Given the high disease burden caused by hypertension in LMICs, nationally representative hypertension care cascades, as constructed in this study, are an important measure of progress towards achieving universal health coverage.

fundingHarvard McLennan Family Fund, Alexander von Humboldt Foundation.

Indexed as

Blood PressureAdolescentAdultAgedAged, 80 and overAge DistributionAntihypertensive AgentsCross-Sectional StudiesDeveloping CountriesFemaleGlobal HealthHealth SurveysHumansHypertensionMaleMiddle AgedAntihypertensive Agents

Identifiers

PMID31327566
OpenAlexW2962471769

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.